Your browser doesn't support javascript.
loading
Medication use and drug-related problems among women at maternity wards-a cross-sectional study from two Norwegian hospitals.
Smedberg, J; Bråthen, M; Waka, M S; Jacobsen, A F; Gjerdalen, G; Nordeng, H.
Afiliación
  • Smedberg J; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, School of Pharmacy, University of Oslo, PO Box 1068, Blindern, 0316, Oslo, Norway.
  • Bråthen M; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, School of Pharmacy, University of Oslo, PO Box 1068, Blindern, 0316, Oslo, Norway.
  • Waka MS; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, School of Pharmacy, University of Oslo, PO Box 1068, Blindern, 0316, Oslo, Norway.
  • Jacobsen AF; Department of Obstetrics, Women and Children's Clinic, Ullevål, Oslo University Hospital, PO Box 4956, Nydalen, 0424, Oslo, Norway.
  • Gjerdalen G; Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, Oslo, 0318, Norway.
  • Nordeng H; Maternity Ward Unit, Department of Gynecology and Obstetrics, Drammen Hospital, Vestre Viken Hospital Trust, PO Box 800, 3004, Drammen, Norway.
Eur J Clin Pharmacol ; 72(7): 849-57, 2016 Jul.
Article en En | MEDLINE | ID: mdl-27023461
ABSTRACT

PURPOSE:

There is a lack of knowledge about drug-related problems (DRPs) among pregnant and lactating women. The aim of this study was to determine the extent and type of DRPs among pregnant and lactating women in the maternity ward at two Norwegian hospitals. We also aimed to investigate which drugs were involved in the identified DRPs, and the outcome of solving the DRPs.

METHODS:

Patient-reported treatment reviews were performed to assess the prevalence and type of DRPs among women at the two maternity wards.

RESULTS:

In all, 212 women were included in the study, of which 89 (42 %) had experienced at least one DRP (105 DRPs in total). "Need for additional drug" (49 cases, 46.7 %) was the most frequent. The most frequent drug group involved in DRPs was drugs acting on the respiratory system, and the most common intervention was raising awareness/providing confidence/giving information during the patient-reported treatment review.

CONCLUSIONS:

Over four out of ten women in the maternity wards have DRPs, and many have questions about drug use during pregnancy and lactation. Many of the DRPs could probably be avoided by providing patient-reported treatment reviews to pregnant women as a part of antenatal care. Multidisciplinary collaboration including physicians, midwifes, and pharmacists in antenatal care and in maternity ward could possibly prevent DRPs and thereby promote patient safety for pregnant and lactating women.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Servicio de Ginecología y Obstetricia en Hospital / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Eur J Clin Pharmacol Año: 2016 Tipo del documento: Article País de afiliación: Noruega

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Servicio de Ginecología y Obstetricia en Hospital / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Eur J Clin Pharmacol Año: 2016 Tipo del documento: Article País de afiliación: Noruega